A study says that one infusion of oritavancin worked as well as the 10-day regimen now used to treat serious bacterial skin infections. [Category: Drugs (Pharmaceuticals), Antibiotics, Medicines Company|MDCO|NASDAQ, Methicillin-Resistant Staphylococcus Aureus] http://rss.nytimes.com/c/34625/f/640346/s/3b2c100d/sc/14/l/0L0Snytimes0N0C20A140C0A60C0A50Chealth0Csingle0Edose0Eof0Eantibiotic0Efound0Eeffective0Ein0Equelling0Emrsa0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm
Read More
No comments:
Post a Comment